• Daniel Kazdal, Michael Menzel, Jan Budczies, and Albrecht Stenzinger.
• Dtsch. Med. Wochenschr. 2023 Sep 1; 148 (18): 115711651157-1165.

AbstractMolecular pathological diagnostics plays a central role in personalized oncology and requires multidisciplinary teamwork. It is just as relevant for the individual patient who is being treated with an approved therapy method or an individual treatment attempt as it is for prospective clinical studies that require the identification of specific therapeutic target structures or complex biomarkers for study inclusion. It is also of crucial importance for the generation of real-world data, which is becoming increasingly important for drug development. Future developments will be significantly shaped by improvements in scalable molecular diagnostics, in which increasingly complex and multi-layered data sets must be quickly converted into clinically useful information. One focus will be on the development of adaptive diagnostic strategies in order to be able to depict the enormous plasticity of a cancer disease over time.Thieme. All rights reserved.

22 keywords...

hide…